Bile Acid Malabsorption Clinical Trial
Official title:
Treatment of Bile Acid Malabsorption With Liraglutide
Comparing the effect of Liraglutide on bile acid malabsorption, with colesevelam
The overall objective of the present study is to provide proof of concept that treatment with the GLP-1 receptor agonist liraglutide is efficacious (as assessed by symptom relief, i.e. response to treatment) and safe (as assessed by adverse effects) in the management of BAM and that it improves bile acid reabsorption (as assessed by SeHCAT) in these patients. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03876717 -
Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea
|
Phase 4 | |
| Terminated |
NCT01203254 -
Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease
|
Phase 4 | |
| Completed |
NCT02628626 -
A Study of Colesevelam in Fecal Incontinence
|
Phase 3 | |
| Completed |
NCT02078856 -
Double-blind, Randomised Study of A3384 in BAM/BAD
|
Phase 2 | |
| Completed |
NCT03059537 -
Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea
|
Phase 4 | |
| Completed |
NCT03168555 -
Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy
|
Phase 4 | |
| Recruiting |
NCT05245357 -
Impact of Foods on Bile Acids, Metabolites, and Inflammation
|
N/A | |
| Completed |
NCT03270085 -
Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption
|
Phase 2 | |
| Completed |
NCT05130047 -
Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)
|
Phase 2 |